• Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Egger M, May M, Chene G et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360, 119129.
  • Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 13351342.
  • Ferro-Luzzi A, Sette S, Franklin M & James WP (1992) A simplified approach of assessing adult chronic energy deficiency. European Journal of Clinical Nutrition 46, 173186.
  • Florence E, Lundgren J, Dreezen C et al. (2003) Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Medicine 4, 255262.
  • Frangakis CE & Rubin DB (2001) Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring. Biometrics 57, 333342.
  • Geng EH, Emenyonu N, Bwana MB, Glidden DV & Martin JN (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300, 506507.
  • Geng EH, Bangsberg DR, Musinguzi N et al. (2009) Understanding Reasons for and Outcomes of Patients Lost to Follow-up in Antiretroviral Therapy Programs in Africa through a Sampling-based Approach. JAIDS epub 10, 405411.
  • Gilks CF, Crowley S, Ekpini R et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368, 505510.
  • Ivers LC, Kendrick D & Doucette K (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases 41, 217224.
  • Johannessen A, Naman E, Ngowi BJ et al. (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases 8, 52.
  • Kaufmann GR, Furrer H, Ledergerber B et al. (2005) Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases 41, 361372.
  • Kiragga A, Castelnuovo B, Kambugu A, Schaefer P, Kamya M & Easterbrook P (2008) Validation of the Quality of Data Collection in a Large Observational Clinic Database in Uganda Using a Nested Research Cohort. International Workshop on HIV Observational Databases, Malaga.
  • Lawn SD, Myer L, Harling G, Orrell C, Bekker LG & Wood R (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 43, 770776.
  • Lin DY (2000) On fitting Cox’s proportinal hazards models to survey data. Biometrika 87, 3747.
  • Lucas SB, De Cock KM, Hounnou A et al. (1994) Contribution of tuberculosis to slim disease in Africa. BMJ 308, 15311533.
  • Maskew M (2008) Gender Differences in HIV Outcomes in South African Patients Receiving Highly Active Antiretroviral Therapy. 2008 HIV/AIDS Implementer’s Meeting, Kampala.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
  • Rothman KJ & Greenland S (2008) Modern Epidemiology. Lippincott, Philadelphia.
  • Schafer JL (1999) Multiple imputation: a primer. Statistical Methods in Medical Research 8, 315.
  • Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296, 782793.
  • Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS 22, 873882.
  • Wools-Kaloustian K, Kimaiyo S, Diero L et al. (2006) Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 20, 4148.
  • Yiannoutsos CT, An MW, Frangakis CE et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3, e3843.